Valuation Black Diamond Therapeutics, Inc.
Stocks
BDTX
US09203E1055
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.840 USD | +0.55% |
|
+1.66% | -24.28% |
| 06-29 | Black Diamond Therapeutics, Inc.(NasdaqGS:BDTX) added to Russell 2000 Index | CI |
| 06-29 | Black Diamond Therapeutics, Inc.(NasdaqGS:BDTX) added to Russell 2000 Value Benchmark | CI |
Company Valuation: Black Diamond Therapeutics, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 193.1 | 65.46 | 145.1 | 121.1 | 138.4 | 105.4 | - | - |
| Change | - | -66.1% | 121.66% | -16.54% | 14.33% | -23.85% | - | - |
| Enterprise Value (EV) | -16.69 | -57.35 | 145.1 | 121.1 | 138.4 | 105.4 | 105.4 | 105.4 |
| Change | - | -243.68% | 353.01% | -16.54% | 14.33% | -23.85% | 0% | 0% |
| P/E | -1.54x | -0.71x | -1.49x | -1.69x | 6.23x | -2.84x | -1.83x | -1.76x |
| PBR | 0.98x | - | - | - | - | - | - | - |
| PEG | - | 0x | 0.1x | 0.1x | -0x | 0x | -0x | -0.42x |
| Capitalization / Revenue | - | - | - | - | 1.98x | 19x | - | - |
| EV / Revenue | - | - | - | - | 0x | 19x | - | - |
| EV / EBITDA | 0x | 0x | - | -0x | 0x | -2.27x | -2.06x | -1.65x |
| EV / EBIT | 0x | 0x | -0x | -0x | 0x | -2.36x | -1.42x | -1.08x |
| EV / FCF | 0x | 0x | -0x | -0x | 0x | -2.51x | -2.4x | 6.59x |
| FCF Yield | -53.3% | -130% | -46% | -51.5% | 21.4% | -39.8% | -41.7% | 15.2% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -3.47 | -2.52 | -1.88 | -1.27 | 0.39 | -0.6478 | -1.005 | -1.047 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | - | - | - | - | 70 | 5.556 | - | - |
| EBITDA 1 | -126.7 | -92.32 | - | -78.44 | 20.2 | -46.4 | -51.15 | -63.9 |
| EBIT 1 | -126.9 | -92.83 | -86.46 | -78.78 | 19.87 | -44.69 | -74.05 | -97.58 |
| Net income 1 | -125.6 | -91.17 | -82.44 | -69.68 | 22.37 | -40.47 | -70.04 | -94.17 |
| Net Debt | -209.8 | -122.8 | - | - | - | - | - | - |
| Reference price 2 | 5.330 | 1.800 | 2.810 | 2.140 | 2.430 | 1.840 | 1.840 | 1.840 |
| Nbr of stocks (in thousands) | 36,229 | 36,366 | 51,635 | 56,585 | 56,975 | 57,302 | - | - |
| Announcement Date | 17/03/22 | 09/03/23 | 12/03/24 | 06/03/25 | 16/03/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.84x | - | - | - | 105M | |
| 21.08x | 6.49x | 14.2x | 1.51% | 55.92B | |
| 33.57x | 8.33x | 25.41x | 0.06% | 56.67B | |
| -18.45x | 4.44x | -7.77x | -.--% | 23.28B | |
| -42.05x | 13.36x | -39.35x | -.--% | 23.28B | |
| 25.7x | 5.07x | 13.38x | -.--% | 20.54B | |
| 24.87x | 4.83x | 15.68x | -.--% | 17.78B | |
| -617.89x | 37.85x | -1571.42x | -.--% | 15.9B | |
| 44.16x | 17.85x | 45.97x | 0.08% | 14.64B | |
| 17.51x | 5.07x | 11.83x | -.--% | 13.99B | |
| Average | -51.43x | 11.48x | -165.79x | 0.18% | 24.21B | |
| Weighted average by Cap. | -25.97x | 9.81x | -92.78x | 0.37% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- BDTX Stock
- Valuation Black Diamond Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
